Long-Term Follow-Up of De Novo Use of mTOR and Calcineurin Inhibitors After Kidney Transplantation-Reference-Cited by-同舟云学术

Long-Term Follow-Up of De Novo Use of mTOR and Calcineurin Inhibitors After Kidney Transplantation

Published:2016-02 Issue:1 Volume:38 Page:22-31
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Ivani de Paula Mayara,Medina Pestana José Osmar,Nicolau Ferreira Alexandra,Pontello Cristelli Marina,Fabiano Franco Marcello,Aguiar Wilson Ferreira,Tedesco-Silva Hélio,Rosso Felipe Claudia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference36 articles.

1. . Sirolimus in renal transplantation.;Morath;Nephrol Dial Transplant,2007

2. . Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients.;Tedesco Silva;Am J Transplant,2010

3. . Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.;Felipe;Fundam Clin Pharmacol,2009

4. . Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes.;Shihab;Transpl Immunol,2014

5. . Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival.;Meier-Kriesche;Am J Transplant,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preliminary assessment of safety and adherence to a once‐daily immunosuppression regimen in kidney transplantation: Results of a randomized controlled pilot study;Clinical Transplantation;2020-03-16

2. The Interferon-Gamma +874 A/T Polymorphism Is Not Associated With CMV Infection After Kidney Transplantation;Frontiers in Immunology;2020-01-08

3. Graft Versus Host Disease (GHVD) in Critically Ill Oncologic Patients;Oncologic Critical Care;2019-10-13

4. Prospective randomized study comparing everolimus and mycophenolate sodium in de novo kidney transplant recipients from expanded criteria deceased donor;Transplant International;2019-08-27

5. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients;Kidney International;2019-07